Dieter Koeberle

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller et al. · Journal of Clinical Oncology · 2007 · 590 citations

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen et al. · Annals of Oncology · 2019 · 232 citations · Full text

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort

Oliver Gautschi, Julie Milia, Bastien Cabarrou et al. · Journal of Thoracic Oncology · 2015 · 186 citations · Full text

Medicine, Pathology, European Euraf Cohort +8

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma

Sebastian Theurich, Sacha I. Rothschild, Michael Hoffmann et al. · Cancer Immunology Research · 2016 · 144 citations

Immunology, Immunoediting, Pathology +17

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Dieter Koeberle, Daniel Betticher, Roger von Moos et al. · Annals of Oncology · 2015 · 139 citations · Full text

Sakk 41/06, Gastrointestinal Oncology, Medicine +9